A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape.

Sabarwal, Akash; Chakraborty, Samik; Mahanta, Simran; Banerjee, Selina; Balan, Murugabaskar; Pal, Soumitro

Sabarwal, Akash; Chakraborty, Samik; Mahanta, Simran; Banerjee, Selina; Balan, Murugabaskar; Pal, Soumitro.

Afiliação

Sabarwal A; Division of Nephrology, Boston Children's Hospital, Boston, MA 02115, USA.
Chakraborty S; Harvard Medical School, Boston, MA 02115, USA.
Mahanta S; Division of Nephrology, Boston Children's Hospital, Boston, MA 02115, USA.
Banerjee S; Harvard Medical School, Boston, MA 02115, USA.
Balan M; Division of Nephrology, Boston Children's Hospital, Boston, MA 02115, USA.
Pal S; Harvard Medical School, Boston, MA 02115, USA.

Cancers (Basel) ; 12(7)2020 Jul 03.

Article em En | MEDLINE | ID: mdl-32635337

Palavras-chave

Honokiol; PD-L1; c-Met; mTOR inhibitor; receptor tyrosine kinase; renal cell carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google